Humacyte, Inc. (HUMAW) NASDAQ
0.06
-0.0149(-21.32%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.06
-0.0149(-21.32%)
Currency In USD
| Market Cap | 151.91M |
| Enterprise Value | 166.26M |
| P/E Ratio | -2.82 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 115.83 |
| Price/Book Ratio | 23.66 |
| Enterprise/Revenue | 124.45 |
| Enterprise/EBITDA | -2.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -48.41 |
| Operating Margin | -56.49 |
| Return On Assets | -0.88 |
| Return On Equity | -27.82 |
| Revenue | 2.04M |
| Revenue/Share | 0.01 |
| Gross Profit | -15.01M |
| EBITDA | -100.09M |
| Net Income | -40.83M |
| Diluted EPS | -0.26 |
| Total Cash | 48.54M |
| Total Cash/Share | 0.25 |
| Total Debt | 65.9M |
| Total Debt/Equity | 5.67 |
| Current Ratio | 3.93 |
| Book Value Per Share | 0.06 |
| 52-Week Change | -89.62 |
| 52-Week High | 0.23 |
| 52-Week Low | 0.04 |
| Moving Average 50 Days | 0.09 |
| Moving Average 200 Days | 0.16 |
| Average Volume | 17,753.26 |
| Shares Outstanding | 1.2B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |